EUVIMEDEUVIMED entdecken
Crossref

Exploring the Patent Landscape and Regulatory Prospective on Pharmaceutical Cocrystals

Ritu Rathi, Yukta Guggal, Twinkle ., Varneet Sandhu, Inderbir Singh

Journal of Pharmaceutical Technology, Research and Management · 15.04.2023 · 11 (1) · 49-60

DOI: 10.15415/jprtm.2023.111005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Technology, Research and Management, online erschienen am 15.04.2023. Verfasst von Ritu Rathi und 4 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cocrystals are not new, they have sparked considerable interest among scientists and the pharmaceutical business in the last decade. Cocrystals are multiphase formations composed of at least two particles that are held together by noncovalent bonds. Cocrystal offers unmatched physio-engineered attributes (like stability, melting point, taste concealment, dissolvability, purity, bioavailability, etc.) without changing the pharmacological capabilities of the drug. Recently, as pharmaceutical cocrystal development has increased, we have given more attention to the absurd state of cocrystals.

Purpose

The purpose of the current review is to explore the patent perspective on pharmaceutical cocrystals. And to discuss the new regulations that came up from the U.S. Food and Drug Administration (USFDA) and European Medicines Agency (EMA).

Methods

In order to accomplish the said objectives, literature was surveyed from GOOGLE PATENTS, GOOGLE SCHOLAR, PUBMED, EBSCO, etc. type for search engines for a detailed overview of the patentability and regulatory status of pharmaceutical cocrystals.

Conclusions

The journey of pharmaceutical cocrystals is bit challenging and still going on. In addition, if attention is drawn on some challenging aspects such as scalability, reproducibility, herbal bioactives cocrystals and 3D printed cocrystals related preparation and stability challenges, it can prove to be a paradigm shift in drug discovery processes.

Zitieren

APA

Rathi, R., Guggal, Y., ., T., Sandhu, V., & Singh, I. (2023). Exploring the Patent Landscape and Regulatory Prospective on Pharmaceutical Cocrystals. Journal of Pharmaceutical Technology, Research and Management, 11(1), 49-60. https://doi.org/10.15415/jprtm.2023.111005

Vancouver

Rathi R, Guggal Y, . T, Sandhu V, Singh I. Exploring the Patent Landscape and Regulatory Prospective on Pharmaceutical Cocrystals. Journal of Pharmaceutical Technology, Research and Management. 2023;11(1):49-60. doi:10.15415/jprtm.2023.111005

BibTeX
@article{Rathi2023,
  author = {Rathi, Ritu and Guggal, Yukta and ., Twinkle and Sandhu, Varneet and Singh, Inderbir},
  title = {Exploring the Patent Landscape and Regulatory Prospective on Pharmaceutical Cocrystals},
  journal = {Journal of Pharmaceutical Technology, Research and Management},
  year = {2023},
  volume = {11},
  number = {1},
  pages = {49--60},
  doi = {10.15415/jprtm.2023.111005}
}
Kostenlos starten →